Works matching IS 17528054 AND DT 2021 AND VI 14 AND IP 3
Results: 42
In vitro safety "clinical trial" of the cardiac liability of drug polytherapy.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1155, doi. 10.1111/cts.13038
- By:
- Publication type:
- Article
Assessing the impact of COVID‐19 on registered interventional clinical trials.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1147, doi. 10.1111/cts.13034
- By:
- Publication type:
- Article
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1133, doi. 10.1111/cts.13011
- By:
- Publication type:
- Article
Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1123, doi. 10.1111/cts.13007
- By:
- Publication type:
- Article
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1101, doi. 10.1111/cts.13001
- By:
- Publication type:
- Article
Approval success rates of drug candidates based on target, action, modality, application, and their combinations.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1113, doi. 10.1111/cts.12980
- By:
- Publication type:
- Article
Adherence to triple‐component antihypertensive regimens is higher with single‐pill than equivalent two‐pill regimens: A randomized controlled trial.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1185, doi. 10.1111/cts.12979
- By:
- Publication type:
- Article
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1176, doi. 10.1111/cts.12977
- By:
- Publication type:
- Article
Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID‐19: A simulation study.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1092, doi. 10.1111/cts.12976
- By:
- Publication type:
- Article
Hybrid physiologically‐based pharmacokinetic model for remdesivir: Application to SARS‐CoV‐2.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1082, doi. 10.1111/cts.12975
- By:
- Publication type:
- Article
Contextualizing single‐arm trials with real‐world data: An emulated target trial comparing therapies for neovascular age‐related macular degeneration.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1166, doi. 10.1111/cts.12974
- By:
- Publication type:
- Article
Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 784, doi. 10.1111/cts.12973
- By:
- Publication type:
- Article
Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1069, doi. 10.1111/cts.12972
- By:
- Publication type:
- Article
Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1062, doi. 10.1111/cts.12971
- By:
- Publication type:
- Article
Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1049, doi. 10.1111/cts.12969
- By:
- Publication type:
- Article
Characterization of LY2775240, a selective phosphodiesterase‐4 inhibitor, in nonclinical models and in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1037, doi. 10.1111/cts.12968
- By:
- Publication type:
- Article
Rigor and reproducibility training for first year medical students in research pathways.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1026, doi. 10.1111/cts.12966
- By:
- Publication type:
- Article
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1015, doi. 10.1111/cts.12965
- By:
- Publication type:
- Article
Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 1002, doi. 10.1111/cts.12964
- By:
- Publication type:
- Article
A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 990, doi. 10.1111/cts.12963
- By:
- Publication type:
- Article
Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 976, doi. 10.1111/cts.12962
- By:
- Publication type:
- Article
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 964, doi. 10.1111/cts.12961
- By:
- Publication type:
- Article
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 954, doi. 10.1111/cts.12960
- By:
- Publication type:
- Article
Population pharmacokinetic and exposure‐response analyses of ivosidenib in patients with IDH1‐mutant advanced hematologic malignancies.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 942, doi. 10.1111/cts.12959
- By:
- Publication type:
- Article
Effect of meal timing on pharmacokinetics and pharmacodynamics of tegoprazan in healthy male volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 934, doi. 10.1111/cts.12958
- By:
- Publication type:
- Article
Adverse event profiles of epidermal growth factor receptor‐tyrosine kinase inhibitors in cancer patients: A systematic review and meta‐analysis.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 919, doi. 10.1111/cts.12957
- By:
- Publication type:
- Article
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 908, doi. 10.1111/cts.12956
- By:
- Publication type:
- Article
Drugs used for the treatment of cerebral and disseminated infections caused by free‐living amoebae.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 791, doi. 10.1111/cts.12955
- By:
- Publication type:
- Article
The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 777, doi. 10.1111/cts.12954
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection as a trigger of autoimmune response.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 898, doi. 10.1111/cts.12953
- By:
- Publication type:
- Article
Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 781, doi. 10.1111/cts.12952
- By:
- Publication type:
- Article
Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non‐small cell lung cancer with sensitive EGFR mutations.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 890, doi. 10.1111/cts.12951
- By:
- Publication type:
- Article
Outreach to new mothers through direct mail and email: recruitment in the Early Check research study.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 880, doi. 10.1111/cts.12950
- By:
- Publication type:
- Article
A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP‐458) in Healthy Adult Volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 870, doi. 10.1111/cts.12947
- By:
- Publication type:
- Article
Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 859, doi. 10.1111/cts.12946
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT‐1: Influence on <sup>18</sup>F‐FDG PET Uptake.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 847, doi. 10.1111/cts.12943
- By:
- Publication type:
- Article
Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long‐Term Survival in Gastric Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 837, doi. 10.1111/cts.12940
- By:
- Publication type:
- Article
Effects on the Ocular Surface from Reading on Different Smartphone Screens: A Prospective Randomized Controlled Study.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 829, doi. 10.1111/cts.12933
- By:
- Publication type:
- Article
Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 806, doi. 10.1111/cts.12898
- By:
- Publication type:
- Article
A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Rising‐Dose Study of the BTK Inhibitor TAK‐020 in Healthy Subjects.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 820, doi. 10.1111/cts.12871
- By:
- Publication type:
- Article
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 812, doi. 10.1111/cts.12859
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 773, doi. 10.1111/cts.12820
- Publication type:
- Article